Full-Time

Regional Sales Director

Employer Sales

Posted on 10/31/2025

9amHealth

9amHealth

51-200 employees

Virtual cardiometabolic care with personalized plans

Compensation Overview

$115k - $150k/yr

+ Commission

United States

Remote

Flexible working model; some roles remote while others in-office; San Diego preferred.

Category
Sales & Account Management (1)
Requirements
  • Demonstrated track record of consistently meeting or exceeding sales quotas in the digital health or employer benefits space.
  • Established relationships with key decision makers in the employer benefits and/or healthcare consulting industries.
  • Deep understanding of employer benefits ecosystems, including the decision-making processes within large employers and benefits consulting firms.
  • Ready to establish and refine a launch strategy for adoption within employers, while working independently to execute
  • Strong leadership abilities and entrepreneurial spirit
Responsibilities
  • Utilize past experiences, relationships, and market knowledge to drive new business with large national employers and employer benefits consultants
  • Lead end-to-end commercial sales opportunities from sourcing to managing the pipeline to closing deals
  • Identify new market opportunities and drive execution
  • Build key relationships with market partners such as health plans and PBMs
Desired Qualifications
  • Expertise in negotiating complex contracts, particularly with large employers and enterprise level accounts.
  • Previous experience working in a fast paced, high growth environment, with comfort navigating ambiguity

9amHealth provides virtual cardiometabolic care to prevent and manage chronic conditions like diabetes, obesity, high cholesterol, and hypertension. The service uses a B2B2C model with employers, health plans, and PBMs, and also offers a direct-to-consumer subscription. Its platform delivers personalized treatment plans, access to endocrinologists and pharmacists, at-home lab testing, connected devices, and prescription delivery, guided by step-therapy from lifestyle changes and generics to GLP-1s when needed. Partnerships with Novo Nordisk, Eli Lilly, and pharmacy networks help expand affordable access to medications, while the goal is to improve outcomes by making cardiometabolic care more accessible and effective.

Company Size

51-200

Company Stage

Series B

Total Funding

$55.2M

Headquarters

San Diego, California

Founded

2021

Simplify Jobs

Simplify's Take

What believers are saying

  • Expansion into autoimmune conditions addresses 24 million Americans requiring expensive specialty care.
  • GLP-1 partnerships with Novo Nordisk and Eli Lilly position 9amHealth in $100B+ obesity market.
  • Referenceable Fortune 100 case studies accelerate B2B2C partnerships with mid-market employers and plans.

What critics are saying

  • Expansion into autoimmune conditions dilutes cardiometabolic focus, risking execution failures and delayed profitability.
  • GLP-1 price deflation and generic competition erode $284/member/month pharmacy savings advantage within 12 months.
  • Cigna investor-competitor relationship enables in-house model replication and partnership defunding within 24 months.

What makes 9amHealth unique

  • AI-enabled clinical workflows deliver 4x ROI and $284 monthly savings per member.
  • Step-therapy model prioritizes generics before expensive GLP-1s, aligning with payer cost preferences.
  • Proven Fortune 100 partnerships generated $50M+ in projected medical and pharmacy savings.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at 9amHealth who can refer or advise you

Benefits

Health Insurance

Vision Insurance

Dental Insurance

Paid Vacation

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

-7%

1 year growth

-12%

2 year growth

-9%
FinSMEs
Feb 20th, 2024
9amHealth Raises $9.5M in Series A Extension Funding

9amHealth, a San Diego, CA-based virtual provider of cardiometabolic health care, raised $9.5M in Series A extension funding.

Trending Topics
Jul 4th, 2023
Calm/Storm Ventures: After The Foundation Comes The Storm

Calm/Storm Ventures has strong roots with business angel Hansi Hansmann, Speedinvest, and Runtastic. After the first focus on HealthTech, the next fund is about financing the best founders in Austria. 2021 was a hype year that doubled the number of unicorns worldwide to 1,058 from 586 in 2020 after massive amounts of venture capital were pumped into these tech companies. Everything was different in 2022, when mass layoffs, downrounds, and a lack of venture capital dominated the headlines. The founders and partners of the Austrian VC Calm/Storm Ventures know these two poles very well. Taken together, Lucanus Polagnoli (ex-Speedinvest), Hansi Hansmann, and Alfred Luger (ex-Runtastic) weigh in on more than 180 investments as fund managers and business angels

Trending Topics
Jun 23rd, 2023
Push Ventures: Startup-Fonds Mit Rückenwind

Nach jahrelanger Erfahrung als „einfacher“ Investor ­startete PUSH Ventures im ­vergangenen Jahr einen ersten großen und ­registrierten Investment-Fonds. Lukas Püspök und Laurenz Simbruner, die beiden Partner hinter dem VC, ­konnten den Fonds mit etwas mehr als 20 Millionen Euro auffüllen. Investiert werden soll in Health- sowie ­Climate-Startups — mit jeder Menge (familiären) Rückenwind. Der Fokus auf Klima-Startups verwundert nicht, blickt doch gerade Familie Püspök auf jahrelange Projekte in diesem Sektor zurück: Seit 1997 beschäftigt sich das Familienunternehmen mit der Stromerzeugung aus erneuerbarer Energie. Vor mehr als 20 Jahren begann die Geschichte mit der Entwicklung und Errichtung eines der ersten Windparks im Burgenland. Über zwei Jahrzehnte später setzt die nächste Generation die nächsten Schritte, gemeinsam mit Laurenz Simbruner und Investment-Manager David Aigner

Trending Topics
Jun 2nd, 2023
Calm/Storm Ventures: Nach Der Gründung Kommt Der Sturm

Calm/Storm Ventures hat mit Business Angel Hansi Hansmann, Speedinvest und Runtastic kräftige Wurzeln. Nach dem ersten Fokus auf HealthTech geht es beim nächsten Fonds darum, die besten Gründer:innen Österreichs zu finanzieren. 2021 war ein Hype-Jahr, das die Zahl der Unicorns weltweit von 586 im Jahr 2020 auf 1.058 verdoppelte, nachdem enorme Mengen an Risikokapital in diese Tech-Firmen gepumpt wurden. 2022 war alles anders, da dominierten Massenkündigungen, Downrounds und fehlendes Risikokapital die Schlagzeilen. Diese beiden Pole kennen die Gründer und Partner des österreichischen VCs Calm/Storm Ventures genau. Zusammengerechnet bringen Lucanus Polagnoli (Ex-Speedinvest), Hansi Hansmann und Alfred Luger (Ex-Runtastic) mehr als 180 Investments als Fonds-Manager bzw

Brutkasten
Jul 14th, 2022
Return On Art Kooperiert Mit 325 Alter Institution

Die Investment-Firma PUSH Ventures gibt es seit 2017. Davor investierten die beiden Gründer Lukas Püspök (Business Angel of the Year 2018) und Laurenz Simbruner bereits einige Jahre in Startups. In dieser Zeit stieg man bei Unternehmen wie Whatchado, mySugr oder Hitbox ein. Später kamen Namen wie Anyline, mostly AI oder Allcyte hinzu. Die Aufzählung der (erfolgreichen) Portfolio-Startups ließe sich noch eine Zeit lang fortsetzen. Was das Investment-Unternehmen bislang aber noch nicht hatte, war ein eigener VC-Fonds. PUSH Ventures: Ein Fonds fürs Fundraisen

INACTIVE